PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

ViiV Healthcare UK (No.5) Limited

USPTO PatentsView assignee record - 51 granted patents across 9 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Viiv ranks #6,605 of 49,997 tracked US assignees by granted-patent volume, with 51 patents across 9 technology areas.

#6,605
of 49,997 US assignees by volume
49th percentile
by Innovation Score (34.8/100)
11.4
avg claims per patent
-62%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6605 · Foreign Corporation #6,605 · 51 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 51 grants
  • UPPER-Q #6,605/49,997
  • PHOTO-FINISH Tower Manufacturing
  • CPC-NARROW A61P · 9 areas
  • INNOV-THIN 34.8/100
  • CLAIMS-PAR 11.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -62% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Tower Manufacturing Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Viiv’s 34.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Viiv

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Viiv's Innovation Score is 34.8/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Viiv?

Each dot is one of Viiv’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Viiv’s own 11.4 claims/patent is at or below the 12.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Viiv vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 50.951.051.05151.051.051.1 510152025 Granted patents (volume) Avg claims / patent Tower Manufacturing Corp. - 51, 7.08Tower Manufacturi…University OF Leicester - 51, 13.75University OF Lei…VTV Therapeutics LLC - 51, 14.57VTV TherapeuticsVestel Elektronik Sanayi ve Ticaret A. S. - 51, 12.9Vestel Elektronik…Waldemar Link GmbH & Co. KG - 51, 16.61Waldemar Link & KGWapp Tech Corp. - 51, 8.22Wapp TechXenon Pharmaceuticals Inc. - 51, 21.88Xenon Pharmaceuti…Yoshino Gypsum Co., Ltd. - 51, 11.27Yoshino GypsumViiV Healthcare UK (No.5) Limited - 51, 11.37Viiv Healthcare U…
Viiv vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Viiv's grants concentrate

ViiV Healthcare UK (No.5) Limited is a focused PatentsView assignee: 9 CPC subclasses with 94.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (15 grants) versus a trough of 1 in 2023. By volume, Viiv sits between Tower Manufacturing Corp. and Yoshino Gypsum Co., Ltd..

Viiv's three-year grant acceleration

ViiV Healthcare UK (No.5) Limited shows 9 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at ViiV's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows ViiV holds 51 patents at rank #6,606, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near ViiV

By rank, the assignees closest to #6,606 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in ViiV's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ViiV, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), ViiV ranks #374 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Varonis Systems, Inc. 35 Javad Gnss, Inc. 35 Kotobuki & Co., Ltd. 35 Hamilton Associates, Inc. 35

Similar claim depth

Nearest assignees by average claims per patent (11.4 here).

Shenzhen Carku Technology Co., Limited 11.4 avg R A Brands L.L.C. 11.4 avg Fujian Jinhua Integrated Circuit Co., Ltd. 11.4 avg Panduit Corp. 11.4 avg

Viiv's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 201620172018201920202021202220232024 5
USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
ViiV Healthcare UK (No.5) Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 3 5.9%
2017 8 15.7%
2018 15 29.4%
2019 11 21.6%
2020 2 3.9%
2021 3 5.9%
2022 3 5.9%
2023 1 2.0%
2024 5 9.8%

Which technologies does ViiV Healthcare UK (No.5) Limited patent most?

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ViiV Healthcare UK (No.5) Limited's patent record in context - here's where to go next.

  • ViiV Healthcare UK (No.5) Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 94.1% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #6,605 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare ViiV Healthcare UK (No.5) Limited against Tower Manufacturing Corp., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 34.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.